Servier Symphogen A/S: Financial statements 2014
CVR: 10013267
Source: annual report 2014, Danish Business Authority
01/01/2014 – 31/12/2014
Servier Symphogen A/S (CVR 10013267) has filed annual accounts for 2014. In 2014, the company reported revenue of DKK 98,742,000 and a net result of DKK -122,564,000. The profit margin was -124.1%. Equity in the 2014 report amounted to DKK 221,894,000. The solvency ratio was 79.3%.
- Revenue
- DKK 98,742,000
- Profit/Loss
- DKK -122,564,000
- Equity
- DKK 221,894,000
- Total Assets
- DKK 279,990,000
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2014
As of October 10, 2014, EY Godkendt Revisionspartnerselskab has been appointed auditor of Servier Symphogen A/S.
As of October 10, 2014, JUT NR. 2180 A/S has stepped down as auditor of Servier Symphogen A/S.
Servier Symphogen A/S has published its annual report for 2013.
About Servier Symphogen A/S
Servier Symphogen A/S is a Danish company of the type Aktieselskab based in Ballerup, founded in 2000. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named SYMPHOGEN A/S and THERAMAB ApS. The management consists of Christophe Jacques Alain Henri Thurieau. The board consists of Claude Philippe Bertrand (chair), Benoit Alain Antoine Chéron, Christophe Jacques Alain Henri Thurieau and Pascal Lemaire. The company is owned by Les Laboratoires Servier. The company has 197 employees (2026). In 2025, the company reported revenue of DKK 593,829,000 and a net result of DKK 39,133,000 compared with DKK 37,336,000 the year before. Equity in the 2025 report amounted to DKK 162,857,000.